内克塔治疗
36.81
+1.69
+4.81%
NKTR
02-06 16:00:00(美东时间)
高
37.26
开
35.18
量
41.66万股
总市值
7.49亿
低
34.47
换
2.05%
额
1516.38万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
内克塔治疗(NKTR)
01-31 03:25
$内克塔治疗(NKTR)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000212 Act: 34 Size: 7 KB
网页链接
内克塔治疗(NKTR)
01-28 05:05
$内克塔治疗(NKTR)$
8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-26-008210 Act: 34 Size: 187 KB
网页链接
内克塔治疗(NKTR)
01-23 08:35
$内克塔治疗(NKTR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-019843 Size: 5 KB
网页链接
内克塔治疗(NKTR)
01-21 05:25
$内克塔治疗(NKTR)$
144 Report of proposed sale of securities Accession Number: 0001959173-26-000377 Act: 33 Size: 6 KB
网页链接
内克塔治疗(NKTR)
2025-12-24 07:05
$内克塔治疗(NKTR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-331187 Size: 7 KB
网页链接
内克塔治疗(NKTR)
2025-12-24 07:05
$内克塔治疗(NKTR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-331189 Size: 7 KB
网页链接
内克塔治疗(NKTR)
2025-12-16 21:05
$内克塔治疗(NKTR)$
8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-320009 Act: 34 Size: 17 MB
网页链接
内克塔治疗(NKTR)
2025-11-26 09:35
$内克塔治疗(NKTR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-297855 Size: 10 KB
网页链接
内克塔治疗(NKTR)
2025-11-26 09:35
$内克塔治疗(NKTR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-297850 Size: 11 KB
网页链接
内克塔治疗(NKTR)
2025-11-26 09:35
$内克塔治疗(NKTR)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-297852 Size: 10 KB
网页链接
内克塔治疗(NKTR)
2025-11-26 04:45
$内克塔治疗(NKTR)$
144 Report of proposed sale of securities Accession Number: 0001959173-25-007276 Act: 33 Size: 7 KB
网页链接
内克塔治疗(NKTR)
2025-11-26 04:35
$内克塔治疗(NKTR)$
144 Report of proposed sale of securities Accession Number: 0001959173-25-007274 Act: 33 Size: 5 KB
网页链接
内克塔治疗(NKTR)
2025-11-26 04:35
$内克塔治疗(NKTR)$
144 Report of proposed sale of securities Accession Number: 0001959173-25-007275 Act: 33 Size: 4 KB
网页链接
内克塔治疗(NKTR)
2025-11-22 05:15
$内克塔治疗(NKTR)$
8-K Current report, items 5.02 and 9.01 Accession Number: 0001213900-25-113606 Act: 34 Size: 189 KB
网页链接
内克塔治疗(NKTR)
2025-11-15 05:45
$内克塔治疗(NKTR)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-112619 Act: 34 Size: 11 KB
网页链接
内克塔治疗(NKTR)
2025-11-15 05:35
$内克塔治疗(NKTR)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-283066 Act: 34 Size: 11 KB
网页链接
内克塔治疗(NKTR)
2025-11-14 06:55
$内克塔治疗(NKTR)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001446580-25-000123 Act: 34 Size: 12 KB
网页链接
内克塔治疗(NKTR)
2025-11-13 05:25
$内克塔治疗(NKTR)$
S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-25-109222 Act: 33 Size: 383 KB
网页链接
内克塔治疗(NKTR)
2025-11-13 05:15
$内克塔治疗(NKTR)$
S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001193125-25-277535 Act: 33 Size: 1 MB
网页链接
内克塔治疗(NKTR)
2025-11-13 05:15
$内克塔治疗(NKTR)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-277570 Act: 33 Size: 457 KB
网页链接